By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Imprimis Pharmaceuticals 

12264 El Camino Real
Suite 350
San Diego  California  92130-0001  U.S.A.
Phone: 858-704-4040 Fax: 858-345-1745


Key Statistics

Ownership: Public

Web Site: Imprimis
Symbol: immy

Company News
Imprimis (immy) To Make A Lower Cost Compounded And Customizable Alternative To Thiola 2/10/2016 7:35:19 AM
Imprimis (immy) Announces National Account Agreement With The Cataract & Laser Institute 12/17/2015 7:59:11 AM
Imprimis (immy) Reports Results Of Independent Third Party Potency Analysis Of Its Compounded Pyrimethamine And Leucovorin Capsules 12/14/2015 6:49:05 AM
Imprimis (immy) Announces Third Quarter 2015 Financial Results And Provides Business Update 11/12/2015 4:32:25 PM
Imprimis (immy)' Ophthalmic Formulations To Be Presented At The 2015 American Academy of Ophthalmology Meeting 11/12/2015 10:44:45 AM
Imprimis (immy) Announces Plans To Register Its Texas Pharmacy With The FDA As An Outsourcing Facility 10/29/2015 10:08:15 AM
Imprimis (immy) Announces New Economic Study Demonstrating $8.7 Billion In Potential Cost Savings Over The Next 10 Years With The Adoption Of Dropless Therapy 10/26/2015 12:04:36 PM
Imprimis (immy) Offers $1 Alternative to Turing Pharma's $750 AIDS Drug 10/22/2015 10:48:02 AM
Imprimis Pharmaceuticals (immy) Announces Preliminary Revenue For Third Quarter 2015 10/20/2015 11:24:00 AM
Imprimis Pharmaceuticals (immy) Closes The Acquisition Of The Assets Of The Largest Provider Of Compounded Sinus Medications In The U.S. 10/20/2015 8:32:20 AM